|
Mechanism30S subunit inhibitors [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.LB |
First Approval Date22 Jul 2016 |
Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Societá Industria Farmaceutica Italiana Spa (S.I.F.I.)
0 Patents (Medical) associated with Societá Industria Farmaceutica Italiana Spa (S.I.F.I.)
100 Deals associated with Societá Industria Farmaceutica Italiana Spa (S.I.F.I.)
100 Translational Medicine associated with Societá Industria Farmaceutica Italiana Spa (S.I.F.I.)